Visit-to-visit HbA1c variability is associated with poor prognosis in peritoneal dialysis patients with type 2 diabetes mellitus

[1] Yang X(2013)Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study Diabetes Res Clin Pract 100 354-361

[2] Yi C(2021)Associations between diabetes and sex with peritoneal dialysis technique and patient survival: results from the Australia and New Zealand Dialysis and Transplant Registry cohort study Perit Dial Int 41 57-68

[3] Liu X(2020)Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes Kidney Int Suppl (2011) 10 e3-e9

[4] Chen JH(2020)Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment Kidney Int 98 839-848

[5] Johnson DW(2011)Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus Clin J Am Soc Nephrol 6 1041-1048

[6] Wong G(2010)Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease Am J Nephrol 31 375-379

[7] Pecoits-Filho R(2014)Hemoglobin A1c in patients on peritoneal dialysis: how should we interpret it? Ther Apher Dial 18 375-382

[8] Okpechi IG(2018)Glycemic variation and cardiovascular risk in the veterans affairs diabetes trial Diabetes Care 41 2187-2194

[9] Donner JA(2016)Carotid intima-media thickness and visit-to-visit HbA1c variability predict progression of chronic kidney disease in type 2 diabetic patients with preserved kidney function J Diabetes Res 2016 3295747-269

[10] de Boer IH(2018)Characteristics of people with high visit-to-visit glycaemic variability in Type 2 diabetes Diabet Med 35 262-432

[1] Yang X(2013)Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study Diabetes Res Clin Pract 100 354-361

[2] Yi C(2021)Associations between diabetes and sex with peritoneal dialysis technique and patient survival: results from the Australia and New Zealand Dialysis and Transplant Registry cohort study Perit Dial Int 41 57-68

[3] Liu X(2020)Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes Kidney Int Suppl (2011) 10 e3-e9

[4] Chen JH(2020)Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment Kidney Int 98 839-848

[5] Johnson DW(2011)Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus Clin J Am Soc Nephrol 6 1041-1048

[6] Wong G(2010)Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease Am J Nephrol 31 375-379

[7] Pecoits-Filho R(2014)Hemoglobin A1c in patients on peritoneal dialysis: how should we interpret it? Ther Apher Dial 18 375-382

[8] Okpechi IG(2018)Glycemic variation and cardiovascular risk in the veterans affairs diabetes trial Diabetes Care 41 2187-2194

[9] Donner JA(2016)Carotid intima-media thickness and visit-to-visit HbA1c variability predict progression of chronic kidney disease in type 2 diabetic patients with preserved kidney function J Diabetes Res 2016 3295747-269

[10] de Boer IH(2018)Characteristics of people with high visit-to-visit glycaemic variability in Type 2 diabetes Diabet Med 35 262-432